Nabeshima Taisuke, Sato Seiichi, Nakayashiro Mami
1Department of Pediatric Cardiology,Okinawa Nambu and Children's Medical Center,Okinawa,Japan.
Cardiol Young. 2019 Jan;29(1):90-92. doi: 10.1017/S1047951118001750. Epub 2018 Oct 30.
Subtotal tumour resection is used to treat infants with congenital cardiac fibroma and medication-resistant ventricular arrhythmias; however, complete elimination of arrhythmogenic substrates has been unclear. A 4-month-old male infant with congenital cardiac fibroma and ventricular fibrillation underwent subtotal tumour resection and implantable cardioverter-defibrillator implantation. Five years later, angiography revealed impending compression of the left coronary artery. Elimination of the arrhythmogenic substrate was confirmed and the device was removed successfully.
